Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: A randomized controlled trial

Journal of Tropical Pediatrics

Volumn 60, Issue 4, 2014, Pages 297-302

  Tewari, Vishal Vishnu ^a   Jain, Naveen ^a  

^a Kerala Institute of Medical Sciences   (India)

Author keywords

Amikacin; Empirical therapy; Monotherapy; Piperacillin tazobactum

Indexed keywords

AMIKACIN; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; PENICILLANIC ACID; PIPERACILLIN; PIPERACILLIN, TAZOBACTAM DRUG COMBINATION;

ARTICLE; BIRTH WEIGHT; BLOOD CULTURE; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FUNGEMIA; HUMAN; INDIA; MONOTHERAPY; MORTALITY; NEWBORN; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEPSIS; ANALOGS AND DERIVATIVES; BACTERIAL INFECTIONS; DRUG COMBINATION; DRUG EFFECTS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MALE; TREATMENT OUTCOME;

AMIKACIN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG THERAPY, COMBINATION; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INDIA; INFANT, NEWBORN; MALE; PENICILLANIC ACID; PIPERACILLIN; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 84905504007     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmu017     Document Type: Article

References (25)

1. Gerdes JS, Polin R. Early diagnosis and treatment of neonatal sepsis. Indian J Pediatr 1998;65:63-78.
2. Karthikeyan G, Premkumar K. Neonatal sepsis: Staphylococcus aureus as the predominant pathogen. Indian J Pediatr 2001;68:715-7.
3. Aurangzeb B, Hameed A. Neonatal sepsis in hospital born babies: bacterial isolates and antibiotic susceptibility patterns. J Coll Physicians Surg Pak 2003;13: 629-32.
4. Kuruvilla KA, Pillai S, Jesudason M. Bacterial profile of sepsis in a neonatal unit in south India. Indian Pediatr 1998;35:851-8.
5. Chacko B, Sohi I. Early onset neonatal sepsis. Indian J Pediatr 2005;72:23-6.
6. National Neonatology Forum. National Neonatal Perinatal Database (NNPD), New Delhi, India; 2002-2003.
7. Vishwanathan R, Singh KA, Mukherjee S. Aetiology and antimicrobial resistance of neonatal sepsis at a tertiary care centre in eastern India: a 3 year study. Indian J Pediatr 2011;78:409-12.
8. Agnihotri N, Kaistha N, Gupta V. Antimicrobial susceptibility of isolates from neonatal septicaemia. Jpn J Infect Dis 2004;57:273-5.
9. Sundaram V, Kumar P, Narang A. Bacterial profile of early versus late onset neonatal sepsis in a north Indian tertiary care centre: heading towards a change. J Pediatr Infectious Dis 2009;4:241-5.
10. Mtitimila EI, Cooke RWI. Antibiotic regimens for suspected early neonatal sepsis. Cochrane Database of Syst Rev 2004;(4):CD004495.
11. Issacs D. Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed 2006;91:F72-4.
12. Placzek M, Whitelaw A, Want S, et al. Piperacillin in early neonatal infection. Arch Dis Child 1983;58: 1006-9.
13. Hammerberg O, Kurnitzki C, Watts J, et al. Randomised trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis. Eur J Clin Microbiol Infect Dis 1989;8:241-4.
14. FlidelRimon O, Freidman S, Leibovitz E, et al. The use of piperacillin/tazobactam (in association with amikacin) in neonatal sepsis: efficacy and safety data. Scand J Infect Dis 2006;38:36-42.
15. Nestaas E, Bangstad HJ, Sandvi KL. Aminoglycoside extended interval dosing in neonates is safe and ffective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2005;90:F294-30.
16. Langhendries JP, Battisti O, Bertrand JM, et al. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit. Biol Neonate 1998;74:351-62.
17. De Hoog M, Mouton JW, Van der Anker JN. New dosing strategies for antibacterial agents in neonates. Semin Fetal Neonat Med 2005;10:185-94.
18. Loughnan PM. Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe? Arch Dis Child Fetal Neonatal Ed 2006;91:F156.
19. Young TE, Mangum B. Drug Dosing in Neonates. Neofax. 22nd edn. New Jersey: Thomson Reuters, 2009; 4-6; 74-5.
20. Metsvaht T, Pisarev H, Ilmoja M, et al. Clinical parameters predicting failure of empirical antibacterial therapy in early onset neonatal sepsis, identified by classification and regression tree analysis. BMC Pediatr 2009;9:72.
21. Tollner U. Early diagnosis of septicaemia in the newborn: clinical studies and sepsis score. Eur J Pediatr 1982;138:331-7.
22. Darmstadt GL, Saha SK, Choi Y. Population-based incidence and etiology of community acquired neonatal bacteremia in Mirzapur, Bangladesh: an observational study. J Infect Dis 2009;200:906-15.
23. Ganatra HA, Stoll BJ, Zaidi AK. International perspective on early onset neonatal sepsis. Clin Perinatol 2010; 37:501-23.
24. Ganatra HA, Zaidi AK. Neonatal infections in the developing world. Semin Perinatol 2010;34:416-25.
25. Lopez Sastre JB, Solis DP, Serradilla VR, et al. Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr 2007;7:9.